P53 PROTEIN EXPRESSION IN HUMAN BREAST-CARCINOMA - RELATIONSHIP TO EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR, C-ERBB-2 PROTEIN OVEREXPRESSION, AND ESTROGEN-RECEPTOR

The expression of p53 protein, oestrogen receptor protein, epidermal growth factor receptor (EGFR) and overexpression of the c-erbB-2 oncoprotein was examined in a series of 149 primary symptomatic breast carcinomas. Expression of p53 was present in 62 of 146 cases (42.5%) of the invasive carcinoma and one of three cases (33.3%) of ductal carcinoma in situ (DCIS) examined. Statistical associations of tumour oestrogen receptor positivity and lack of p53 protein expression, chi-2 = 19.78 (d.f. = 1), P<0.001, positive tumour p53 status and poor tumour grade; chi-2 = 14.1 (d.f. = 2), P < 0.001, EGFR expression chi-2 = 7.07, (d.f. = 1), P < 0.01 and tumour c-erbB-2 protein overexpression; chi-2 = 4.61 (d.f. = 1), P = 0.032 were identified. Expression of p53 is rare in invasive lobular carcinoma of classical type (8.3% of cases examined) in contrast to other common types of mammary carcinoma. Non-significant trends of p53 protein expression and increased regional tumour recurrence; chi-2 = 3.20 (d.f. = 1), P = 0.074 and also poorer patient survival; chi-2 = 3.76 (d.f. = 1), P = 0.053 were identified. p53 protein expression is a common event in human breast cancer and is present in both DCIS and invasive mammary carcinoma. Abnormal expression of p53 protein is a feature of both in situ and invasive breast carcinoma, implying that the abnormal p53 protein expression may be implicated in the early stages of mammary carcinoma progression.